FMSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 7月 2024 @ 01:51):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

Stats
本日の出来高	97 353
平均出来高	398 772
時価総額	11.22B
EPS	$0.240 ( Q1 \| 2024-03-31 )
次の収益日	( $0.380 ) 2024-08-07
Last Dividend	$0.688 ( 2024-05-17 )
Next Dividend	$0 ( N/A )
P/E	21.73 (Sector) 49.64 (Industry) 17.16
ATR14	$0.00700 (0.04%)

AGL -4.82%

AMN -3.20%

ATIP 2.49%

AUNA -1.63%

BKD 3.15%

BKDT 0.00%

CANO -2.13%

CCM 1.05%

CHE -0.56%

CSU -2.09%

CYH -0.74%

DVA 0.47%

EHAB -3.36%

EHC 0.39%

FMS 0.16%

HCA -1.22%

HNGR 0.00%

MD -3.64%

NFH 0.25%

OSH 0.08%

SEM 0.43%

SNDA -1.87%

SOLV -2.51%

THC 0.20%

UHS -0.76%

USPH -1.55%

相関 (AI algo v.1.1b): Undervalued: 0.07% $19.15 paired level. (アルゴリズムは、最も相関の高い株式の変更をリアルタイムで追跡し、即時の更新を提供します)

ボリューム相関

長: 0.09 (neutral)

短: -0.89 (strong negative)

Signal:(51.28) Neutral

Fresenius Medical Care AG 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Fresenius Medical Care AG 相関 - 通貨/商品

0.30
( neutral )

-0.46
( neutral )

0.00
( neutral )

0.88
( strong )

-0.76
( moderate negative )

-0.43
( neutral )

Fresenius Medical Care AG 財務諸表

Annual	2023
収益:	$19.45B
総利益:	$4.93B (25.32 %)
EPS:	$1.700

FY	2023
収益:	$19.45B
総利益:	$4.93B (25.32 %)
EPS:	$1.700

FY	2022
収益:	$19.40B
総利益:	$5.31B (27.37 %)
EPS:	$2.30

FY	2021
収益:	$17.62B
総利益:	$5.08B (28.82 %)
EPS:	$1.655

Financial Reports:

No articles found.

Fresenius Medical Care AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.669 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.688 (N/A)	$0 (N/A)	$0 (N/A)

Fresenius Medical Care AG Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.70 - Stable (13.97%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.102	1998-06-08
Last Dividend	$0.688	2024-05-17
Next Dividend	$0	N/A
Payout Date	2024-06-03
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	$13.35	--
Avg. Dividend % Per Year	3.11%	--
Score	4.39	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.70
Div. Directional Score	7.89	--

Next Divdend (Est)
(2025-04-02)

$0.693 Estimate 6.27 %

Dividend Stability

0.25 Very Poor

Dividend Score

4.39

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
1998	$0.102	0.93%
1999	$0.108	0.89%
2000	$0.101	0.73%
2001	$0.104	0.74%
2002	$0.115	1.11%
2003	$0.197	2.91%
2004	$0.307	2.56%
2005	$0.301	2.25%
2006	$0.309	1.71%
2007	$0.424	1.87%
2008	$0.645	2.44%
2009	$0.505	2.12%
2010	$0.521	1.91%
2011	$0.676	2.35%
2012	$0.589	1.67%
2013	$0.631	1.84%
2014	$0.731	2.10%
2015	$0.497	1.36%
2016	$0.500	1.21%
2017	$0.560	1.32%
2018	$0.739	1.41%
2019	$0.732	2.25%
2020	$0.838	2.26%
2021	$1.018	2.39%
2022	$0.740	2.27%
2023	$0.669	4.15%
2024	$0.688	3.24%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
17 May 2024	$0.688	15 Apr 2024	20 May 2024	03 Jun 2024
17 May 2023	$0.669	03 May 2023	18 May 2023	01 Jun 2023
13 May 2022	$0.740	28 Apr 2022	16 May 2022	27 May 2022
24 May 2021	$1.018	17 May 2021	25 May 2021	07 Jun 2021
28 Aug 2020	$0.838	12 Aug 2020	31 Aug 2020	11 Sep 2020
17 May 2019	$0.732	08 May 2019	20 May 2019	31 May 2019
21 May 2018	$0.739	10 May 2018	22 May 2018	04 Jun 2018
11 May 2017	$0.560	24 Apr 2017	15 May 2017	26 May 2017
10 May 2016	$0.500	09 Mar 2016	12 May 2016	23 May 2016
15 May 2015	$0.497	30 Nov -0001	30 Nov -0001	01 Jun 2015
13 May 2014	$0.731	02 May 2014	15 May 2014	27 May 2014
14 May 2013	$0.631	14 May 2013	16 May 2013	28 May 2013
08 May 2012	$0.589	30 Nov -0001	30 Nov -0001	21 May 2012
10 May 2011	$0.676	30 Nov -0001	30 Nov -0001	23 May 2011
07 May 2010	$0.521	30 Nov -0001	30 Nov -0001	30 Nov -0001
05 May 2009	$0.505	30 Nov -0001	30 Nov -0001	30 Nov -0001
16 May 2008	$0.645	30 Nov -0001	30 Nov -0001	30 Nov -0001
11 May 2007	$0.424	30 Nov -0001	30 Nov -0001	30 Nov -0001
05 May 2006	$0.309	30 Nov -0001	30 Nov -0001	30 Nov -0001
20 May 2005	$0.301	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ECC	Dividend Diamond	2024-07-11	Monthly	11	14.91%	9.72
BRW	Dividend Diamond	2024-06-11	Monthly	33	9.41%	9.26
VVR	Dividend Diamond	2024-06-18	Monthly	27	8.85%	9.19
FCT	Dividend Diamond	2024-06-03	Monthly	21	8.33%	9.14
PHK	Dividend Diamond	2024-06-13	Monthly	22	9.07%	9.13
SBR	Dividend Diamond	2024-06-17	Monthly	38	9.57%	9.10
XFLT	Dividend Diamond	2024-06-17	Monthly	8	10.49%	9.09
SRV	Dividend Royal	2024-07-16	Monthly	18	10.61%	9.04
FAM	Dividend Royal	2024-06-03	Monthly	20	8.07%	8.98
RA	Dividend Diamond	2024-06-11	Monthly	9	10.10%	8.93

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0248	1.500	9.50	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0141	1.200	9.53	10.00	[0 - 0.3]
returnOnEquityTTM	0.0344	1.500	-0.729	-1.094	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.496	0.800	7.52	6.01	[1 - 3]
quickRatioTTM	0.870	0.800	9.59	7.67	[0.8 - 2.5]
cashRatioTTM	0.185	1.500	-0.0831	-0.125	[0.2 - 2]
debtRatioTTM	0.350	-1.500	4.16	-6.24	[0 - 0.6]
interestCoverageTTM	3.28	1.000	9.90	9.90	[3 - 30]
operatingCashFlowPerShareTTM	8.91	2.00	7.03	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.60	2.00	6.70	10.00	[0 - 20]
debtEquityRatioTTM	0.795	-1.500	6.82	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.254	1.000	9.10	9.10	[0.2 - 0.8]
operatingProfitMarginTTM	0.0686	1.000	-0.627	-0.627	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.217	1.000	9.90	9.90	[0.2 - 2]
assetTurnoverTTM	0.567	0.800	9.55	7.64	[0.5 - 2]
Total Score				10.08

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.77	1.000	9.01	0	[1 - 100]
returnOnEquityTTM	0.0344	2.50	-0.469	-1.094	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.60	2.00	7.80	10.00	[0 - 30]
dividendYielPercentageTTM	3.88	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.91	2.00	7.03	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	4.13	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.134	1.000	9.15	0	[0.1 - 0.5]
Total Score				5.70

Fresenius Medical Care AG Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.